Instead of pharmacare, Canadians need faster drug-approval timelines

In October 2024, Ottawa’s national pharmacare legislation received royal assent. The federal government promptly began negotiations with the provinces to provide public coverage for diabetes and contraceptive drugs on a first-dollar, single-payer basis under the plan’s f...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












